Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/09/2011 | CA2791654A1 Ultra-sensitive detection of molecules or particles using beads or other capture objects |
09/09/2011 | CA2791648A1 Antibody specific for apolipoprotein and methods of use thereof |
09/09/2011 | CA2791538A1 Oligomer-specific amyloid beta epitope and antibodies |
09/09/2011 | CA2791535A1 Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases |
09/09/2011 | CA2791361A1 Method for producing soluble recombinant interferon protein without denaturing |
09/09/2011 | CA2789188A1 System for determining treatment-related data for the administration of drugs to patients to be treated taking into account important individual factors |
09/09/2011 | CA2788603A1 System and method for administering medicaments on the basis of urine values |
09/09/2011 | CA2786302A1 System and method for monitoring at least one blood parameter |
09/09/2011 | CA2783665A1 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
09/09/2011 | CA2783656A1 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
09/08/2011 | US20110219464 Lung disease targets and uses thereof |
09/08/2011 | US20110219463 Methods of screening agents for activity using teleosts |
09/08/2011 | US20110219462 G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases |
09/08/2011 | US20110218956 Methods of diagnosing inflammatory bowel disease |
09/08/2011 | US20110218738 Characterization of molecules |
09/08/2011 | US20110218411 Fluid handling cassette system for body fluid analyzer |
09/08/2011 | US20110218379 Epitopes derived from satb2 and uses thereof |
09/08/2011 | US20110218332 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
09/08/2011 | US20110218229 SIRT1 Modulation of Adipogenesis and Adipose Function |
09/08/2011 | US20110218155 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
09/08/2011 | US20110218148 Pharmaceutical composition |
09/08/2011 | US20110218145 Antibodies to modified human igf-1/e peptides |
09/08/2011 | US20110218122 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides |
09/08/2011 | US20110218119 Methods of Screening an Agent for an Activity in an Isolated Eye of a Teleost |
09/08/2011 | US20110218118 Peptide modulators of cellular phenotype and bi-nucleic acid fragment library |
09/08/2011 | US20110218116 Biomarkers of osteoarthritis |
09/08/2011 | US20110218114 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
09/08/2011 | US20110217791 Method for quantifying or detecting dna |
09/08/2011 | US20110217790 Novel CD3 Epsilon Immunogens And Antibodies |
09/08/2011 | US20110217789 Method for analysing molecular pollution of a fluid, application device and application to the analysis of pollution in a natural medium and in a controlled environment |
09/08/2011 | US20110217787 Concentration measuring apparatus for hydrogen sulfide in gas flow, and method for determining sulfide ion |
09/08/2011 | US20110217785 Chitosan-coated wires for biosensing |
09/08/2011 | US20110217784 Method for producing soluble recombinant interferon protein without denaturing |
09/08/2011 | US20110217783 Cleavable surfactants and methods of use thereof |
09/08/2011 | US20110217782 Method for analyzing antimony contained in glass |
09/08/2011 | US20110217753 Inhibitors of extracellular proteases |
09/08/2011 | US20110217732 Method and compositions for the detection of protein glycosylation |
09/08/2011 | US20110217723 Epi-illumination apparatus and methods for sorting particles |
09/08/2011 | US20110217722 Photo-damage apparatus and methods for sorting particles |
09/08/2011 | US20110217720 Compositions and Kits Pertaining to Analyte Determination |
09/08/2011 | US20110217719 Methods and kits for diagnosing obstructive sleep apnea |
09/08/2011 | US20110217718 Methods and Kits for Distinguishing Between Specific and Non-Specific Protein Associations |
09/08/2011 | US20110217716 Method for quantifying skin changes caused by six external evils and method for screening skin condition-improving materials using the same |
09/08/2011 | US20110217713 Biomarkers For The Identification, Monitoring, And Treatment Of Non-Small Cell Lung Cancer (NSCLC) |
09/08/2011 | US20110217708 Methods and compositions for detecting colon cancers |
09/08/2011 | US20110217707 Evaluation/screening method for diseases associated with d-amino acid utilizing da01-/-mouse |
09/08/2011 | US20110217702 Methods for diagnosis of and predicting treatment efficacy of hormone receptor expressing tumors, cancers and neoplasias |
09/08/2011 | US20110217696 Aza-benzazolium containing cyanine dyes |
09/08/2011 | US20110217459 Process for conjugating biomolecules to hydrophobic membrane-incorporated molecules |
09/08/2011 | US20110217401 Aging-Related Circulating Particle-Associated Lipoprotein B Oxidase (apoBNOX) and Inhibitors Thereof |
09/08/2011 | US20110217397 Compositions for controlling insects |
09/08/2011 | US20110217338 HIV-1 Envelope Based Fragments |
09/08/2011 | US20110217325 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
09/08/2011 | US20110217320 Hapten-carrier conjugates for treating and preventing nicotine addiction |
09/08/2011 | US20110217316 GBS Toxin Receptor Compositions and Methods of Use |
09/08/2011 | US20110217310 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology |
09/08/2011 | US20110217306 C-terminal exon 5.4 of runx1/aml1 |
09/08/2011 | US20110217302 TCR Complex Immunotherapeutics |
09/08/2011 | US20110217297 Methods for classifying and treating breast cancers |
09/08/2011 | US20110217292 Monoclonal antibodies against hmgb1 |
09/08/2011 | US20110217288 Involvement of Androgen/Androgen Receptor Pathway in Fabry Disease |
09/08/2011 | US20110217281 Methods for diagnosis and prognosis of cancer |
09/08/2011 | US20110217238 Method of Diagnosing or Prognosing Epithelial Ovarian Cancer |
09/08/2011 | US20110217232 Method for Determination of the Responsiveness of an Individual to Misletoe Lectin |
09/08/2011 | US20110217207 Analysis tool, identification apparatus, and analysis apparatus |
09/08/2011 | US20110217205 Diagnostic radio frequency identification sensors and applications thereof |
09/08/2011 | US20110216319 Device and method for investigating analytes in liquid suspension or solution |
09/08/2011 | US20110216309 Component measurement apparatus |
09/08/2011 | US20110216308 Component measurement apparatus |
09/08/2011 | US20110215277 Method of synthesizing colloidal nanoparticles |
09/08/2011 | US20110215237 Mass Analysis Using Alternating Fragmentation Modes |
09/08/2011 | US20110215111 Method and apparatus for orienting sperm in a fluid stream |
09/08/2011 | US20110215004 Measuring device and methods for use therewith |
09/08/2011 | US20110215002 Sensing device and related methods |
09/08/2011 | US20110214990 Kidney cell carcinoma |
09/08/2011 | US20110214506 Apparatus and method for evaluating mechanical properties of geo-materials |
09/08/2011 | DE102010010715A1 Method for combined continuous analytic multi-measurement of process relevant parameters for e.g. oxygen in water of vapor- and hot water systems in boiler, involves producing calibration medium that is available in process application |
09/08/2011 | DE102010010682A1 Transport case for transporting e.g. blood samples, from e.g. hospital, to laboratory, has absorption part formed by absorption layers that are arranged between and firmly connected with bottom layer and cover layer |
09/08/2011 | DE102010010155A1 Verwendung von halogenierten Cyanozimtsäurederivaten als Matrizes in MALDI-Massenspektrometrie Use of halogenated Cyanozimtsäurederivaten as matrices in MALDI mass spectrometry |
09/08/2011 | DE102010010052A1 Signalgebende Bindemoleküle, Vorrichtungen und Verfahren zu deren Verwendung Signaling binding molecules, devices, and methods of use thereof |
09/08/2011 | DE102010000645A1 Method for phase separation of blood samples during blood examinations in laboratories, involves guiding usage container into sample container before closing sample container, and sealing usage container against its inner wall |
09/07/2011 | EP2363711A1 Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor |
09/07/2011 | EP2363710A1 Isolation and identification of T cells |
09/07/2011 | EP2363709A1 Separation of conjugated and unconjugated components |
09/07/2011 | EP2363501A1 Method for isolating target cells |
09/07/2011 | EP2363500A1 Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative RT-PCR |
09/07/2011 | EP2363498A1 Method for quantitatively determining cholesterol in low-density lipoproteins, reagent for quantitative determination, and quantitative determination kit |
09/07/2011 | EP2363496A1 Pharmacological profiling of drugs with cell-based assays |
09/07/2011 | EP2363488A1 Postweaning multisystemic wasting syndrome virus from pigs |
09/07/2011 | EP2363475A1 Screening method, composition containing substance selected by the screening method, and binding substance |
09/07/2011 | EP2363471A1 Immunoassay method for human cxcl1 protein |
09/07/2011 | EP2363468A1 Tumor antigen peptide and use thereof |
09/07/2011 | EP2363458A2 Terpene synthases |
09/07/2011 | EP2363416A2 Anti-platelet membrane glycoprotein VI monoclonal antibody |
09/07/2011 | EP2363415A2 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance |
09/07/2011 | EP2363413A1 Methods and compositions for the inhibition of modulation of T cell costimulatory pathway by a pathogenic agent |
09/07/2011 | EP2363410A1 Isoforms of MUC1 |
09/07/2011 | EP2363408A2 Genes for modulating coffee maturation and methods for their use |
09/07/2011 | EP2363406A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
09/07/2011 | EP2363405A1 Anti-infarction molecules |